Literature DB >> 21381240

Immunotherapy: Therapeutic potential of genetically modified HBV-specific T cells for chronic HBV infection and HBV-related HCC.

Natalie J Wood.   

Abstract

Entities:  

Year:  2011        PMID: 21381240     DOI: 10.1038/nrgastro.2010.221

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  3 in total

1.  Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer.

Authors:  G K Lau; A S Lok; R H Liang; C L Lai; E K Chiu; Y L Lau; S K Lam
Journal:  Hepatology       Date:  1997-06       Impact factor: 17.425

2.  Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

Authors:  Laura A Johnson; Richard A Morgan; Mark E Dudley; Lydie Cassard; James C Yang; Marybeth S Hughes; Udai S Kammula; Richard E Royal; Richard M Sherry; John R Wunderlich; Chyi-Chia R Lee; Nicholas P Restifo; Susan L Schwarz; Alexandria P Cogdill; Rachel J Bishop; Hung Kim; Carmen C Brewer; Susan F Rudy; Carter VanWaes; Jeremy L Davis; Aarti Mathur; Robert T Ripley; Debbie A Nathan; Carolyn M Laurencot; Steven A Rosenberg
Journal:  Blood       Date:  2009-05-18       Impact factor: 22.113

3.  Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines.

Authors:  Adam J Gehring; Shao-An Xue; Zi Zong Ho; Denise Teoh; Christiane Ruedl; Adeline Chia; Sarene Koh; Seng Gee Lim; Mala K Maini; Hans Stauss; Antonio Bertoletti
Journal:  J Hepatol       Date:  2010-11-23       Impact factor: 25.083

  3 in total
  2 in total

1.  Impact of T cell selection methods in the success of clinical adoptive immunotherapy.

Authors:  Natalia Ramírez; Lorea Beloki; Miriam Ciaúrriz; Mercedes Rodríguez-Calvillo; David Escors; Cristina Mansilla; Eva Bandrés; Eduardo Olavarría
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

2.  Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells.

Authors:  Mohammad Haque; Jianyong Song; Kristin Fino; Praneet Sandhu; Youfei Wang; Bing Ni; Deyu Fang; Jianxun Song
Journal:  Cell Transplant       Date:  2016-01-15       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.